All In Biotech

Drug Trial Radar · NCT04688320

Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

Multicenter, Open Label, Randomized Comparative Trial of the Efficacy and Safety of a Single Bolus Recombinant Non-immunogenic Staphylokinase and Bolus-infusion of Alteplase in Patients With Massive Pulmonary Embolism (FORPE)

Last checked: Nov 20, 2026Latest source record: Apr 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 310 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

310

Actual

Start

Dec 15, 2020

Primary completion

Jul 27, 2023

Study completion Jul 27, 2023

Sponsor

Lead sponsor
Supergene, LLCIndustry
Sponsor type
Industry
First posted
Dec 29, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objective: to evaluate the efficacy and safety of the Recombinant Non-immunogenic Staphylokinase with its single bolus administration in comparison with the bolus-infusion administration of the Alteplase in patients with massive pulmonary embolism

Conditions

  • Massive Pulmonary Embolism

Interventions

  • Recombinant nonimmunogenic staphylokinaseDrug

    15 mg of drug reconstituted in 10 ml of 0.9% solution of NaCl given as single i.v. bolus over 10-15 seconds

  • AlteplaseDrug

    Alteplase® is administered in accordance with the instructions for use for pulmonary embolism ( 10 mg bolus and 90 mg as IV infusion over 2 hours, maximum 100 mg). In patients weighing less than 65 kg, the total dose should not exceed 1.5 mg / kg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Death From All CausesTime frame: within 7 days

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Belgorod Regional Clinical Hospital of St. Joseph

    Belgorod, Russia

  • Kuzbass Cardiology center

    Kemerovo, Russia

  • Krasnoyarsk Regional Clinical Hospital

    Krasnoyarsk, Russia

  • Kursk Regional Clinical Hospital

    Kursk, Russia

  • D.D. Pletnev City Clinical Hospital

    Moscow, Russia

  • I.V. Davydovskii City Clinical Hospital

    Moscow, Russia

  • S.S. Yudin City Clinical Hospital

    Moscow, Russia

  • V.V. Vinogradov City Clinical Hospital

    Moscow, Russia

  • V.V. Veresaev City Clinical Hospital

    Moscow, Russia

  • N.V. Sklifosovsky Research Institute for Emergency Medicine

    Moscow, Russia

  • S.P. Botkin City Clinical Hospital

    Moscow, Russia

  • Murmansk Regional Clinical Hospital

    Murmansk, Russia

  • N.N. Burdenko Penza Regional Clinical hospital

    Penza, Russia

  • G.A. Zakharyin Clinical hospital №6

    Penza, Russia

  • Saint Petersburg "Mariinskaya" City Hospital

    Saint Petersburg, Russia

  • Holy Martyr Elizabeth Saint Petersburg City Hospital

    Saint Petersburg, Russia

  • V.P. Polyakov Samara Regional Clinical Cardiology Dispensary

    Samara, Russia

  • Saratov Regional Clinical Cardiology Dispensary

    Saratov, Russia

  • Tver Regional Clinical Hospital

    Tver', Russia

  • City Clinical hospital №4

    Vladimir, Russia

  • City Clinical Hospital of Emergency №25

    Volgograd, Russia

  • V.F. Dolgopolov Vyselki Central District Hospital

    Vyselki, Krasnodarskiy Kray, Russia

  • Sergiyev Posad Regional Clinical Hospital

    Sergiyev Posad, Moscow Oblast, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.